Antara Capital’s Envoy Medical COCH Stock Holding History

Antara Capital’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-600,000	Closed	-$5.82M	–	180
2021 Q2	$5.82M	Buy	+600,000	New	+$5.83M	0.32%	51

Other funds holding COCH

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

DAM

DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Antara Capital's COCH Position: Q3 2021 in Review

Antara Capital sold out of Envoy Medical (COCH) in Q3 2021, closing a stake of 600,000 shares — an estimated $5.82M sold.

Antara Capital first reported a position in COCH in Q2 2021 and held it in 1 quarter. The position peaked at $5.82M in Q2 2021. 68 funds tracked by Wall St. Rank hold COCH as of Q3 2021.

Antara Capital reported no remaining Envoy Medical position as of Q3 2021 after selling out during the quarter.
Antara Capital sold 600,000 Envoy Medical shares in Q3 2021, an estimated $5.82M.
Antara Capital first reported a position in Envoy Medical in Q2 2021 and held it in 1 quarter.
Antara Capital's Envoy Medical position peaked at $5.82M in Q2 2021.
68 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2021.

Based on Antara Capital's 13F filing for Q3 2021, filed 15 Nov 2021.